We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-0.91%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$117B
AUM Growth
-$6.8B
Cap. Flow
-$1.96B
Cap. Flow %
-1.67%
Top 10 Hldgs %
30.2%
Holding
4,248
New
63
Increased
1,950
Reduced
1,821
Closed
101

Top Sells

Rank Stock Value
1
IWV icon
iShares Russell 3000 ETF
IWV
+$607M
2
AAPL icon
Apple
AAPL
+$186M
3
MSFT icon
Microsoft
MSFT
+$139M
4
META icon
Meta Platforms (Facebook)
META
+$89.6M
5
NVDA icon
NVIDIA
NVDA
+$74.4M

Sector Composition

Rank Sector Weight
1 Technology 30.6%
2 Financials 12.67%
3 Consumer Discretionary 10.32%
4 Industrials 10.12%
5 Healthcare 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWI icon
3376
iShares MSCI Italy ETF
EWI
$911M
$8.01K ﹤0.01%
150
RAIL icon
3377
FreightCar America
RAIL
$275M
$7.97K ﹤0.01%
1,000
ARAI
3378
Arrive AI Inc
ARAI
$15.3M
$7.96K ﹤0.01%
10,000
+5,714
+133% +$9.07K
TWIN icon
3379
Twin Disc
TWIN
$335M
$7.82K ﹤0.01%
519
VLRS
3380
Controladora Vuela Compania de Aviacion
VLRS
$876M
$7.78K ﹤0.01%
1,074
+34
+3% +$298
IMMP
3381
Immutep
IMMP
$56.7M
$7.73K ﹤0.01%
22,053
-5,097
-19% -$11.7K
IAG icon
3382
IAMGOLD
IAG
$8.47B
$7.7K ﹤0.01%
409
RILY icon
3383
BRC Group Holdings
RILY
$277M
$7.65K ﹤0.01%
1,045
YOUL
3384
Youlife Group Inc
YOUL
$48.5M
$7.25K ﹤0.01%
7,328
-340
-4% -$413
CCCC icon
3385
C4 Therapeutics
CCCC
$376M
$7.14K ﹤0.01%
2,716
ATHE
3386
Alterity Therapeutics
ATHE
$82.3M
$7.01K ﹤0.01%
1,970
-157
-7% -$532
NXXT
3387
NextNRG Inc
NXXT
$50.7M
$6.95K ﹤0.01%
17,372
+1,070
+7% +$843
FRSX
3388
Foresight Autonomous Holdings
FRSX
$4.02M
$6.93K ﹤0.01%
2,785
+828
+42% +$2.45K
HOFT icon
3389
Hooker Furnishings Corp
HOFT
$148M
$6.93K ﹤0.01%
538
ZEPP
3390
Zepp Health
ZEPP
$71.9M
$6.93K ﹤0.01%
580
+5
+0.9% +$102
YB
3391
Yuanbao Inc
YB
$614M
$6.81K ﹤0.01%
386
BRNS
3392
Barinthus Biotherapeutics
BRNS
$24.6M
$6.68K ﹤0.01%
11,685
ACHL
3393
DELISTED
Achilles Therapeutics
ACHL
$6.63K ﹤0.01%
4,480
HKD
3394
AMTD Digital
HKD
$506M
$6.53K ﹤0.01%
4,187
+1,953
+87% +$2.96K
ELME
3395
Elme Communities
ELME
$132M
$6.53K ﹤0.01%
3,248
-250,218
-99% -$824K
MREO
3396
Mereo BioPharma
MREO
$45.9M
$6.45K ﹤0.01%
19,572
+426
+2% +$183
MPTI.RT
3397
DELISTED
M-tron Industries Rights (expiring April 15 2026)
MPTI.RT
$6.39K ﹤0.01%
+3,047
New +$6.4K
API
3398
Agora
API
$326M
$6.31K ﹤0.01%
1,782
-1,164
-40% -$4.93K
HTT
3399
High Templar Tech Ltd
HTT
$377M
$6.28K ﹤0.01%
3,239
HDL
3400
Super Hi International Holding
HDL
$6.1K ﹤0.01%
405

Similar funds

RhumbLine Advisers's Q1 2026 Portfolio in Review

As of Q1 2026, RhumbLine Advisers held 4,248 positions worth $117B, down 5.5% from $124B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q1 2026: portfolio turnover was 3.9%. RhumbLine Advisers opened 63 new positions and exited 101, leaving the 4,248-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q1 2026 buy was Versant Media Group: 361,319 shares worth $13.4M.
  • RhumbLine Advisers added most to Marsh in Q1 2026, an estimated $162M increase.
  • RhumbLine Advisers's biggest Q1 2026 reduction was iShares Russell 3000 ETF, cutting an estimated $607M.
  • RhumbLine Advisers fully exited Everpure Inc in Q1 2026, selling an estimated $58.7M.
  • RhumbLine Advisers's ten largest holdings make up 30% of its $117B portfolio in Q1 2026.
  • RhumbLine Advisers opened 63 new positions and closed 101 in Q1 2026.
  • RhumbLine Advisers's portfolio value fell 5.5% quarter-over-quarter to $117B.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.